Literature DB >> 9925630

Comparative study of biological properties and electrophoretic characteristics of lipopolysaccharide from eel-virulent and eel-A virulent Vibrio vulnificus strains.

E G Biosca1, R M Collado, J D Oliver, C Amaro.   

Abstract

In Vibrio vulnificus, virulence for eels is associated with serovar E strains. In this study, we investigated some biological properties of purified lipopolysaccharides (LPSs) from serovar E and non-serovar E strains. Purified LPSs retained their O-polysaccharidic side chains and did not show any differences that could be related to host specificity, except for serological differences.

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 9925630      PMCID： PMC91109     

Source DB:  PubMed          Journal:  Appl Environ Microbiol        ISSN： 0099-2240            Impact factor:   4.792


  20 in total

1.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

2.  Correlation between virulence and colony morphology in Vibrio vulnificus.

Authors:  L M Simpson; V K White; S F Zane; J D Oliver
Journal:  Infect Immun       Date:  1987-01       Impact factor: 3.441

3.  Detection of lipopolysaccharides by ethidium bromide staining after sodium dodecyl sulfate-polyacrylamide gel electrophoresis.

Authors:  N Kido; M Ohta; N Kato
Journal:  J Bacteriol       Date:  1990-02       Impact factor: 3.490

4.  A sensitive silver stain for detecting lipopolysaccharides in polyacrylamide gels.

Authors:  C M Tsai; C E Frasch
Journal:  Anal Biochem       Date:  1982-01-01       Impact factor: 3.365

5.  Electrophoretic analysis of lipopolysaccharide isolated from opaque and translucent colony variants of Vibrio vulnificus using various extraction methods.

Authors:  K F Bahrani; J D Oliver
Journal:  Microbios       Date:  1991

6.  Studies on the lipopolysaccharide of a virulent and an avirulent strain of Vibrio vulnificus.

Authors:  K Bahrani; J D Oliver
Journal:  Biochem Cell Biol       Date:  1990-02       Impact factor: 3.626

7.  Identification of Vibrio vulnificus O serovars with antilipopolysaccharide monoclonal antibody.

Authors:  S J Martin; R J Siebeling
Journal:  J Clin Microbiol       Date:  1991-08       Impact factor: 5.948

8.  Physiological effects of the lipopolysaccharide of Vibrio vulnificus on mice and rats.

Authors:  V L McPherson; J A Watts; L M Simpson; J D Oliver
Journal:  Microbios       Date:  1991

9.  Role of lipopolysaccharide in opsonization and phagocytosis of Pseudomonas aeruginosa.

Authors:  W Engels; J Endert; M A Kamps; C P van Boven
Journal:  Infect Immun       Date:  1985-07       Impact factor: 3.441

10.  Electrophoretic analysis of heterogeneous lipopolysaccharides from various strains of Vibrio vulnificus biotypes 1 and 2 by silver staining and immunoblotting.

Authors:  C Amaro; E G Biosca; B Fouz; E Garay
Journal:  Curr Microbiol       Date:  1992-08       Impact factor: 2.188
View more
  3 in total

1.  Population genetics of Vibrio vulnificus: identification of two divisions and a distinct eel-pathogenic clone.

Authors:  Michaela Gutacker; Nadine Conza; Cinzia Benagli; Ambra Pedroli; Marco Valerio Bernasconi; Lise Permin; Rosa Aznar; Jean-Claude Piffaretti
Journal:  Appl Environ Microbiol       Date:  2003-06       Impact factor: 4.792

2.  Emergence of a virulent clade of Vibrio vulnificus and correlation with the presence of a 33-kilobase genomic island.

Authors:  Ana Luisa V Cohen; James D Oliver; Angelo DePaola; Edward J Feil; E Fidelma Boyd
Journal:  Appl Environ Microbiol       Date:  2007-07-06       Impact factor: 4.792

3.  Vibrio vulnificus MO6-24/O lipopolysaccharide stimulates superoxide anion, thromboxane B₂, matrix metalloproteinase-9, cytokine and chemokine release by rat brain microglia in vitro.

Authors:  Alejandro M S Mayer; Mary L Hall; Michael Holland; Cristina De Castro; Antonio Molinaro; Monica Aldulescu; Jeffrey Frenkel; Lauren Ottenhoff; David Rowley; Jan Powell
Journal:  Mar Drugs       Date:  2014-03-26       Impact factor: 5.118
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.